You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 9,757,406


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 9,757,406 protect, and when does it expire?

Patent 9,757,406 protects EPCLUSA and is included in one NDA.

Protection for EPCLUSA has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.

This patent has thirty-two patent family members in nineteen countries.

Summary for Patent: 9,757,406
Title:Combination formulation of two antiviral compounds
Abstract: Disclosed are pharmaceutical compositions comprising Compound I, having the formula: ##STR00001## and an effective amount of sofosbuvir wherein the sofosbuvir is substantially crystalline. Also disclosed are methods of use for the pharmaceutical composition.
Inventor(s): Gorman; Eric (Foster City, CA), Mogalian; Erik (Foster City, CA), Oliyai; Reza (Foster City, CA), Stefanidis; Dimitrios (Mountain View, CA), Wiser; Lauren (San Francisco, CA), Zia; Vahid (Palo Alto, CA)
Assignee: Gilead Pharmasset LLC (Foster City, CA)
Application Number:15/282,128
Patent Claim Types:
see list of patent claims
Composition; Compound; Dosage form;
Patent landscape, scope, and claims:

United States Patent 9,757,406: A Detailed Analysis of Scope, Claims, and Patent Landscape

Introduction

United States Patent 9,757,406, titled "Combination formulation of two antiviral compounds," is a significant patent in the field of pharmaceuticals, particularly in the development of antiviral treatments. This article will delve into the scope and claims of this patent, as well as the broader patent landscape in which it resides.

Patent Overview

Title and Abstract

The patent, issued to inventors associated with a pharmaceutical company, describes a combination formulation of two antiviral compounds. The abstract outlines the composition and method of use for this formulation, highlighting its efficacy in treating viral infections[2].

Scope and Claims

Claim Structure

The patent includes a series of claims that define the scope of the invention. These claims are divided into independent and dependent claims, each specifying different aspects of the combination formulation.

  • Independent Claims: These claims define the broadest scope of the invention, including the combination of the two antiviral compounds, their respective concentrations, and the formulation's intended use.
  • Dependent Claims: These claims narrow down the scope by specifying additional details such as the type of viral infections treated, the dosage forms, and any additional components in the formulation.

Key Components

  • Antiviral Compounds: The patent specifies two particular antiviral compounds and their synergistic effect when combined.
  • Formulation: The claims cover various forms of the formulation, including tablets, capsules, and injectable solutions.
  • Therapeutic Use: The patent claims the use of this combination for treating specific viral infections.

Patent Landscape Analysis

Geographical Spread

To understand the geographical spread of this technology, one must look at the global patent landscape. The USPTO's Global Dossier service provides insights into related applications filed at participating IP Offices, including the IP5 Offices (US, Europe, Japan, China, and Korea)[1].

Saturation Level

The patent space for antiviral compounds is highly saturated, with numerous patents and pending applications. A comprehensive patent landscape analysis helps identify the level of saturation and potential opportunities or challenges in this space. For instance, if the space is highly saturated, it may be difficult to secure claims for new filings without infringing existing patents[3].

Competitors and New Entrants

Identifying competitors and new entrants in the antiviral compound space is crucial. This involves analyzing the patent portfolios of key players and monitoring new filings. The USPTO's Patent Public Search tool and international databases like the European Patent Office's esp@cenet and the World Intellectual Property Organization's PATENTSCOPE can provide valuable insights[1].

Time-Slicing and Trends

Time-slicing involves analyzing patent activity over time to identify trends and shifts in technology focus. This can reveal whether certain technologies are being abandoned or if new areas are emerging. For example, if there is a significant decrease in patent filings for a particular type of antiviral compound, it may indicate a shift towards more promising technologies[3].

Niche Patent Areas

Identifying underappreciated niche patent areas can provide strategic advantages. For instance, if a company focuses a significant portion of its resources on a niche technology within the antiviral space, it may uncover opportunities that others have overlooked. This is evident in the example where a company's 25 matters related to a niche technology make up 33% of its entire patent portfolio[3].

Tools and Resources for Analysis

USPTO Resources

  • Patent Public Search: This tool provides enhanced access to prior art and is essential for conducting thorough patent searches.
  • Global Dossier: This service allows users to view the patent family for a specific application, including related applications from participating IP Offices.
  • Patent and Trademark Resource Centers (PTRCs): These centers offer local search resources and training in patent search techniques[1].

International Databases

  • European Patent Office (EPO): esp@cenet provides access to Europe's patent databases and machine translations of European patents.
  • World Intellectual Property Organization (WIPO): PATENTSCOPE offers a full-text search of published international patent applications and machine translations for some documents[1].

Strategic Insights

Patentability vs. Patent Landscape Analysis

While a patentability search focuses on prior art directed to specific claims, a full patent landscape analysis provides a broader view of the entire technology area. This comprehensive approach helps in making long-term decisions about technology development and potential pivots to newer inventive spaces[3].

Counseling and Decision-Making

A detailed patent landscape analysis enables attorneys and IP professionals to provide strategic advice to their clients. For example, if a client is considering investing in a new antiviral drug technology, the analysis will guide them on the potential rewards or perils based on existing patents and market trends[3].

Conclusion

Understanding the scope and claims of United States Patent 9,757,406 requires a thorough analysis of the patent itself as well as the broader patent landscape. This involves using various tools and resources provided by the USPTO and international intellectual property offices. By conducting a comprehensive patent landscape analysis, businesses can make informed decisions about their research, development, and patent prosecution strategies.

Key Takeaways

  • Detailed Claims Analysis: Understand the independent and dependent claims to grasp the full scope of the invention.
  • Global Patent Landscape: Use tools like Global Dossier and international databases to analyze the geographical spread and saturation of the technology area.
  • Competitor Analysis: Identify key competitors and new entrants in the antiviral compound space.
  • Time-Slicing and Trends: Analyze patent activity over time to identify shifts in technology focus.
  • Niche Opportunities: Look for underappreciated niche patent areas for strategic advantages.
  • Strategic Advice: Use patent landscape analysis to guide long-term decisions and provide strategic advice to stakeholders.

FAQs

Q: What is the main focus of United States Patent 9,757,406?

A: The main focus is on a combination formulation of two antiviral compounds and its therapeutic use.

Q: How can one determine the saturation level of the antiviral compound patent space?

A: By conducting a comprehensive patent landscape analysis using tools like the USPTO's Patent Public Search and international databases.

Q: What is the difference between a patentability search and a patent landscape analysis?

A: A patentability search focuses on prior art for specific claims, while a patent landscape analysis provides a broader view of the entire technology area.

Q: How can businesses benefit from a patent landscape analysis?

A: It helps businesses make informed decisions about research, development, and patent prosecution strategies by identifying trends, competitors, and potential opportunities.

Q: Where can one find resources for conducting a thorough patent search?

A: Resources include the USPTO's Patent Public Search, Global Dossier, PTRCs, and international databases like esp@cenet and PATENTSCOPE.

Sources

  1. USPTO - Search for patents: https://www.uspto.gov/patents/search
  2. PubChem - Combination formulation of two antiviral compounds: https://pubchem.ncbi.nlm.nih.gov/patent/US-9757406-B2
  3. AcclaimIP - Patent Landscape Analysis: https://www.acclaimip.com/patent-landscaping/patent-landscape-analysis-uncovering-strategic-insights/
  4. U.S. Department of Commerce - U.S. Patent and Trademark Office: https://www.commerce.gov/bureaus-and-offices/uspto
  5. Unified Patents Portal - US-11192875-B2: https://portal.unifiedpatents.com/patents/patent/US-11192875-B2

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 9,757,406

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Gilead Sciences Inc EPCLUSA sofosbuvir; velpatasvir TABLET;ORAL 208341-002 Mar 19, 2020 RX Yes No ⤷  Subscribe ⤷  Subscribe Y ⤷  Subscribe
Gilead Sciences Inc EPCLUSA sofosbuvir; velpatasvir TABLET;ORAL 208341-001 Jun 28, 2016 RX Yes Yes ⤷  Subscribe ⤷  Subscribe Y ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.